drugset / Trial / NCT02047422
A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS II)
Withdrawn
Yonsei University
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the effectiveness and safety of diuretics add-on strategy in chronic heart failure patients
Timeline
- Start
- 2014-01
- Primary completion
- 2016-02
- Completion
- 2016-02
Outcome
Outcome not reported
Stopped: “One of the diuretic which is planned to be used in the study is no longer available.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Furosemide | Other / unclassified | — | — |
| Subject | Metolazone | Small molecule | 2.5 mg | — |
| Subject | Spironolactone | Small molecule | 12.5 mg | — |